Skip to main content

Table 3 Clinicopathological features and APEX1 and OGG1 gene polymorphisms

From: Association of APEX1 and OGG1 gene polymorphisms with breast cancer risk among Han women in the Gansu Province of China

Clinical features

SNPs

Genotype

N (%)

OR (95% CI)a

P value

Positive

Negative

APEX1

 ER

rs1130409

GG

48(14.55)

38(22.35)

Reference

 

GT

158(47.88)

74(43.53)

1.709(1.028-2.842)

0.039

TT

124(37.58)

58(34.12)

1.725(1.016-2.930)

0.043

Dominantb

  

1.716(1.068-2.759)

0.026

Recessivec

  

1.174(0.796-1.732)

0.417

rs3136817

TT

267(80.91)

130(76.47)

Reference

 

TC

59(17.88)

37(21.76)

0.779(0.491-1.236)

0.288

CC

4(1.21)

3(1.76)

0.673(0.148-3.063)

0.608

Dominant

  

0.771(0.492-1.207)

0.255

Recessive

  

0.708(0.156-3.213)

0.655

 Her-2

rs1130409

GG

27(23.08)

59(15.57)

Reference

 

GT

56(47.86)

176(46.44)

0.689(0.399-1.190)

0.182

TT

34(29.06)

144(37.99)

0.508(0.281-0.917)

0.025

Dominant

  

0.608(0.364-1.015)

0.057

Recessive

  

0.663(0.423-1.040)

0.074

rs3136817

TT

95(81.20)

298(78.63)

Reference

 

TC

21(17.95)

75(19.79)

0.875(0.512-1.497)

0.627

CC

1(0.85)

6(1.58)

0.505(0.060-4.265)

0.531

Dominant

  

0.848(0.501-1.433)

0.537

Recessive

  

0.519(0.062-4.365)

0.546

 Ki-67

rs3136817

TT

239(80.20)

134(77.91)

Reference

 

TC

54(18.12)

36(20.93)

0.842(0.525-1.350)

0.475

CC

5(1.68)

2(1.16)

1.451(0.277-7.610)

0.660

Dominant

  

0.873(0.552-1.383)

0.564

Recessive

  

1.502(0.287-7.854)

0.630

OGG1

 Ki-67

rs2072668

CC

55(18.46)

21(12.21)

Reference

 

CG

146(48.99)

82(47.67)

0.675(0.381-1.195)

0.178

GG

97(32.55)

69(40.12)

0.536(0.297-0.968)

0.039

Dominant

  

0.612(0.355-1.052)

0.076

Recessive

  

0.913(0.620-1.344)

0.644

  1. ER estrogen receptor, Her-2 human epidermal growth factor receptor 2, Ki-67 monoclonal antibody Ki-67, OR odds ratio, CI confidence interval;
  2. aORs were adjusted for age;
  3. bThe dominant model: comparing the combination of heterozygotes and minor allele homozygotes with the major allele homozygotes;
  4. cThe recessive model: comparing minor allele homozygotes with the combination of heterozygotes and major allele homozygotes